|
|
Journal of Cancer 2019
Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative ResectionDOI: 10.7150/jca.28409 Keywords: hepatocellular carcinoma, serum biomarker, S100A9, prognosis, curative resection Abstract: Background: Previous studies suggest S100A9 is a promising biomarker for prognosis in cancer, including hepatocellular carcinoma (HCC). We examined the utility of serum S100A9 in predicting prognosis in HCC after curative resection.
|
